Notably, the relative expression ratio of LAPTM4B to LGR5 demonstrated superior predictive accuracy for CRC recurrence (HR = 7.01; CI, 3.15–15.61; p = 0.00014; Figure 6L). Here, LAPTM4B is linked to colorectal carcinoma.